Journal
ACS MEDICINAL CHEMISTRY LETTERS
Volume 11, Issue 3, Pages 249-257Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acsmedchemlett.9b00453
Keywords
Kinetoplastids; leishmaniasis; Chagas disease; malaria; protozoan parasite inhibitors; parasite-hopping
Categories
Funding
- National Institutes of Health [R01AI082577, R56AI099476, R01AI124046, R21AI127594, R01AI126311]
Ask authors/readers for more resources
Utilizing a target repurposing and parasite-hopping approach, we tested a previously reported library of compounds that were active against Trypanosoma brucei, plus 31 new compounds, against a variety of protozoan parasites including Trypanosoma cruzi, Leishmania major, Leishmania donovani, and Plasmodium falciparum. This led to the discovery of several compounds with submicromolar activities and improved physicochemical properties that are early leads toward the development of chemotherapeutic agents against kinetoplastid diseases and malaria.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available